Costa Rica has become LATAM’s #1 location for the medical devices and pharmaceutical industries boosted by rapidly growing R&D activities. A hub that joins OEMs, with strategic suppliers for resilient supply chain solutions and preferential global market access. Now home to 13 of the top 20 Original Equipment Manufacturers in the MedTech sector, the country’s #1 export product is medical devices and is moving into combined solutions in the pharma industry, such as Bayer’s recent US$200 million investment in Costa Rica.
KEY TOPICS
- Investing in Costa Rica: Reaching the triple bottom line for MedTech in people, planet, and prosperity.
- Resilient Supply Chains: The Success of developing local suppliers to avoid disruption.
- Achieving Efficiencies: Discover Costa Rica’s enabling capabilities and growth ecosystems.
- Enabling R&D: Opportunities and key factors to innovate from Costa Rica.
- Converging technologies: How is Costa Rica integrating in the new MedTech?
